Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H · HKEX:2335

Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H financial statements

Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024
Revenue00
Research and development130.1M107.0M
Selling, general and administrative7.77M6.22M
Operating income-153.3M-125.1M
Depreciation and amortization6.57M8.39M
EBITDA-146.7M-116.7M
Interest expense67.0M37.6M
Income before tax-184.9M-156.8M
Net income-182.5M-154.6M
Earnings per share, basic-0.55-0.47

Balance sheet

LineFY2025FY2024
Cash and equivalents80.6M64.7M
Short-term investments155.5M115.2M
Current assets262.2M186.0M
Total assets331.5M247.3M
Accounts payable53.7M33.4M
Current liabilities266.4M77.9M
Long-term debt042.3M
Total liabilities1.29B120.5M
Shareholders' equity-972.5M111.8M
Shares outstanding331.7M331.7M

Cash flow

LineFY2025FY2024
Cash from operations-137.1M-107.7M
Capital spending-17.0M-1.30M
Free cash flow-154.1M-109.0M
Change in cash17.5M-31.8M